Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infection...( PARIS November 6 /- - Tria...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Date:11/6/2009
PARIS, November 6 /PRNewswire/ --
- Trial Will Compare NXL103 With Leading Oral Agent Linezolid for the Treatment of Multi-Resistant Staphylococcus Aureus (MRSA) Infections
Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today that its most advanced oral antibacterial NXL103 (flopristin/linopristin), has started a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI). The trial is designed to assess the safety and efficacy of NXL103 in comparison to oral linezolid (Zyvox, Pfizer NYSE:PFE).
The comparative Phase II trial with NXL103 is a prospective, multicenter, investigator-blinded, two-arm, parallel group study carried out in adults, either in hospital or as outpatients, with ABSSSI. Patients will be randomized to receive either NXL103 (500 mg twice a day) or linezolid (600mg twice a day), with 120 patients receiving NXL103 and 60 receiving linezolid. The treatment period in both study arms will be between 10 and 14 days.
The primary endpoint of the study is the clinical outcome in the clinically evaluable population at the Test of Cure (TOC) visit (7 days post-therapy). Secondary end points of the study include microbiological response at the TOC visit as well as evaluating the tolerability and safety of NXL103.
This comparative Phase II study is expected to recruit a total of 180
patients from approximately 20 sites in the USA and Central America. The
study is expected to be completed in 2010 and is a critical part of Novexel's
clinical development plan for NXL103 which is focused on its potential to be
used in hospitals and out-patients as an oral agent for the treatment of
infections caused by Gram-positive organisms, including MRSA. Currently,
physicians have a limited choice of a
'/>"/>
| SOURCE Novexel Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
2. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
3. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
4. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
5. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
6. AMT Starts Development LPLChip(TM) With Progenika
7. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
8. R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
9. BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
10. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
11. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
Post Your Comments:
(Date:11/25/2009)...erland,Nov.25/PRNewswire/-- FromNovember16-18,Phon...ons,presentedthesecondeditionoftheHearingCareforAd...population.Theconferencebroughttogetherleadingexpe...n250clinicianswhoworkeverydaywitholderpeoplewithhe...ussthelatestresearchandtrendsinhearingcareforolder...
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--Formanyofthemillionsof...ingwithuntreated hearingloss ,theholidaysmaynotbea...yer,seniorvicepresidentofHearUSA(Amex: EAR ),oneof...es,saidstudieshavelinkedhearinglosstostress,frustr...iedatholidaygatheringswithfamiliesandfriends,whenm...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 1Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 2Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 3Outsourcing of IT Requirements by Healthcare Organisations Promotes All Round Benefits Says Frost 26 Sullivan 53729 4Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients 53726 1Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients 53726 2Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients 53726 3Novo Nordisk Appoints Per Falk M D Ph D as Vice President for Clinical Medical and Regulatory Affairs for North America 53723 1Novo Nordisk Appoints Per Falk M D Ph D as Vice President for Clinical Medical and Regulatory Affairs for North America 53723 2...fective Against Difficult-to-Treat Skin Inf...n-resistant Staphylococcus aureus (MRSA), NEW YOR...) today announced positive results from two global...taroline, a broad-spectrum,cephalosporin with acti...and gram negative bacteria, for the treatment of c...
...tion,(Nasdaq: BPUR ) announced today that the U.S...ed a new protocol for review by the Food and Drug,...of Hemopure(R),[hemoglobin glutamer - 250 (bovine)...asualties with severe traumatic hemorrhagic shock ...oposed trial hypotheses is that,for such casualtie...
Other Medicine Technology:Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 2Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 3Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 4U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 2U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 3(Date:11/26/2009)...ations announces a highly effective and unconventi...ng to make an economic recovery. , ...s the type of challenge that could send ailing hol... David Benton, business growth expert and author o...; The Rfactor Intensive . “Fear is one of...
(Date:11/25/2009)...re-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ...toreventsinDecember: ,, ASHBriefing ,, ...ncipalinvestigatorswilldiscussdatapresentationssur...plemyeloma,asfeaturedatthe51stAmericanSocietyofHem...,LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a....
(Date:11/25/2009)...e-USNewswire/--AnarticlebyJanetWoodcock,M.D.,direc...tled"ADifficultBalance-PainManagement,DrugSafety,a...andJournalofMedicine. ,, (Logo: http://www.news...earticle,WoodcockdiscussesFDAeffortstostrikeabalan...dmanagingtherisksposedbyvariousanalgesics.Asexampl...
(Date:11/25/2009)...r who were treated with cisplatin-based chemothera...gical side effects and Raynaud-like phenomena, tha...rding to a new study published online November 25 ... , Marianne Brydy, M.D., of the Department of On...Norway, and colleagues conducted a cross-sectional...
(Date:11/25/2009)...to draw definite conclusions, experts say, , ...diabetic patients with blocked coronary arteries, ...ne year whether patients undergo bypass surgery or...port. , Bypass surgery has been the standard tr... disease. However, less invasive approaches such a...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3[0] Pharmacist Injects Cure for Ailing Businesses [0] Onyx Pharmaceuticals Announces December 2009 Investor Events[1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine[0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects[1] Stenting May Equal Bypass for Diabetic Heart Patients
... has raised questions about plans recently announc...to launch a campaign// promoting male circumcision... Organization and UNAIDS as a way to help reduce t...ot decided if it will pursue the campaign. UNAIDS ...
...g in the happiness of her 27th marriage anniversar...en she began to suffer// hot flashes, she dismisse...y Mandy was pregnant, but didn’t think so even in ...ing lunch, Mandy experienced a chilling pain in th...
...ws with one more ailment added to its list of expl... enhanced risk of colon cancer. //
Scientist...e unearthed the link between obesity and cancer of... cells grow in the colon, rectum and appendix of s...
...) is urgently reminding the public that contact wi...infants//, small children, and adults with impaire...almonella, a group of bacteria that can cause seve...et turtle in the home.
Salmonella is the ge...
... claims to be the world's oldest inhabited city. I...
Its population of 1.74 millions is said to be ...ry where water is a scarce commodity, whatever wat... shrub whose leaves, when you chew them, can induc...
...isk of developing colon cancer, the third most com...cells in the body of obese people produce leptin -...er. The more fat cells a person has, the more lept... in the colon, rectum and appendix.
Research...
Other Medicine News:Health News:NYC Mayor Raises Questions About Male Circumcision as HIV Prevention Method 2Health News:FDA Re-Emphasizes Warnings to Consumers on Risks of Pet Turtles 2Health News:Drug Uses Up Water in Yemeni Capital, People Must Relocate 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |